BillionToOne, Inc.

BillionToOne develops blood tests that detect disease by counting DNA molecules. Their prenatal test, called UNITY Complete, screens for birth defects and genetic conditions using just a maternal blood sample. They also offer cancer tests that identify mutations in tumors and measure how much cancer is present in the blood, allowing doctors to track whether treatment is working without needing a tissue biopsy.